Published in Br J Haematol on December 30, 2012
Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease. Osteoporos Int (2016) 0.99
Pain over time and its effects on life in thalassemia. Am J Hematol (2013) 0.78
Variance of pain prevalence and associated severity during the transfusion cycle of adult thalassaemia patients. Br J Haematol (2014) 0.75
Assessment and treatment of pain in thalassemia. Ann N Y Acad Sci (2016) 0.75
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA (2003) 8.18
Response-guided telaprevir combination treatment for hepatitis C virus infection. N Engl J Med (2011) 6.31
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood (2005) 6.07
Successes and challenges of HIV prevention in men who have sex with men. Lancet (2012) 4.94
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood (2005) 4.79
Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis (2011) 4.72
Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. JAMA (2006) 4.65
Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents--second edition. Pediatr Crit Care Med (2012) 4.65
AIDS. Promote HIV chemoprophylaxis research, don't prevent it. Science (2005) 4.44
Pulmonary complications of sickle cell disease. N Engl J Med (2008) 4.11
A broadly implementable research course in phage discovery and genomics for first-year undergraduate students. MBio (2014) 3.93
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood (2002) 3.70
Complications of beta-thalassemia major in North America. Blood (2004) 2.97
Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood (2003) 2.92
Neuropsychological function in children with blood lead levels <10 microg/dL. Neurotoxicology (2007) 2.31
Factors associated with self-efficacy for condom use and sexual negotiation among South african youth. J Acquir Immune Defic Syndr (2006) 2.21
Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res (2005) 2.18
Hyperbaric oxygen therapy for traumatic brain injury: a systematic review of the evidence. Arch Phys Med Rehabil (2004) 2.16
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. Eur J Haematol (2007) 2.14
Left ventricular reconstruction: Early and late results. J Thorac Cardiovasc Surg (2004) 2.06
Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants. Pediatr Res (2007) 2.02
Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr (2003) 2.00
Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol (2006) 1.99
Social networking technologies as an emerging tool for HIV prevention: a cluster randomized trial. Ann Intern Med (2013) 1.97
The longevity of amalgam versus compomer/composite restorations in posterior primary and permanent teeth: findings From the New England Children's Amalgam Trial. J Am Dent Assoc (2007) 1.88
Thalassemia. Hematology Am Soc Hematol Educ Program (2004) 1.83
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood (2009) 1.83
HIV-related stigma, social norms, and HIV testing in Soweto and Vulindlela, South Africa: National Institutes of Mental Health Project Accept (HPTN 043). J Acquir Immune Defic Syndr (2010) 1.78
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol (2007) 1.77
The relationship between online social networking and sexual risk behaviors among men who have sex with men (MSM). PLoS One (2013) 1.74
Linkage to HIV care and survival following inpatient HIV counseling and testing. AIDS Behav (2011) 1.66
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood (2004) 1.66
Effective dosing of lipid A analogue E5564 in rats depends on the timing of treatment and the route of Escherichia coli infection. J Infect Dis (2006) 1.61
Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res (2009) 1.61
Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. AIDS (2007) 1.60
Renal effects of dental amalgam in children: the New England children's amalgam trial. Environ Health Perspect (2008) 1.60
Implementation and evaluation of an HIV/STD intervention in Peru. Eval Program Plann (2006) 1.55
Hypothermia treatment for traumatic brain injury: a systematic review and meta-analysis. J Neurotrauma (2008) 1.55
A dose-effect analysis of children's exposure to dental amalgam and neuropsychological function: the New England Children's Amalgam Trial. J Am Dent Assoc (2007) 1.54
Vulnerability and sexual risks: Vagos and vaguitas in a low income town in Perú. Cult Health Sex (2006) 1.53
Test and tell: correlates and consequences of testing and disclosure of HIV status in South Africa (HPTN 043 Project Accept). J Acquir Immune Defic Syndr (2009) 1.53
Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda. PLoS One (2011) 1.50
Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med (2004) 1.49
Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J Acquir Immune Defic Syndr (2009) 1.46
Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS One (2011) 1.46
Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease. Br J Haematol (2011) 1.45
Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2003) 1.45
Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion (2013) 1.43
A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J (2014) 1.40
Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). PLoS One (2013) 1.40
The impact of a video intervention on the use of low vision assistive devices. Optom Vis Sci (2007) 1.39
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Am J Hematol (2007) 1.39
Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool. J Pain Symptom Manage (2002) 1.27
Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. Haematologica (2008) 1.26
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial. PLoS One (2013) 1.24
Potential for false positive HIV test results with the serial rapid HIV testing algorithm. BMC Res Notes (2012) 1.24
Moderno love: sexual role-based identities and HIV/STI prevention among men who have sex with men in Lima, Peru. AIDS Behav (2013) 1.24
Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload. Br J Haematol (2009) 1.23
Gene interactions and stroke risk in children with sickle cell anemia. Blood (2003) 1.23
Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr Hematol Oncol (2002) 1.22
Looking to the future: South African men and women negotiating HIV risk and relationship intimacy. Cult Health Sex (2011) 1.22
Non-transfusion-dependent thalassemias. Haematologica (2013) 1.21
Burden of restless legs syndrome on health-related quality of life. Qual Life Res (2007) 1.21
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica (2008) 1.18
Sexual risk and HIV prevention behaviours among African-American and Latino MSM social networking users. Int J STD AIDS (2013) 1.17
Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer (2007) 1.17
Mobile VCT: reaching men and young people in urban and rural South African pilot studies (NIMH Project Accept, HPTN 043). AIDS Behav (2013) 1.17
Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol (2009) 1.15
Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer (2009) 1.15
Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis (2006) 1.13
Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms. Am J Hematol (2011) 1.13
The HOPE social media intervention for global HIV prevention in Peru: a cluster randomised controlled trial. Lancet HIV (2015) 1.13
Effect of a community popular opinion leader HIV/STI intervention on stigma in urban, coastal Peru. AIDS Behav (2011) 1.11
Project HOPE: online social network changes in an HIV prevention randomized controlled trial for African American and Latino men who have sex with men. Am J Public Health (2014) 1.11
Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol (2011) 1.10
Pain as an emergent issue in thalassemia. Am J Hematol (2010) 1.10
A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease. Am J Hematol (2012) 1.09
Barriers to adherence of deferoxamine usage in sickle cell disease. Pediatr Blood Cancer (2005) 1.08
Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait. J Natl Med Assoc (2006) 1.06
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Clin Ther (2007) 1.06
Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major. Br J Haematol (2008) 1.05
Validation of the German version of the brief fatigue inventory. J Pain Symptom Manage (2003) 1.05
[Influence of socio-cultural context on risk perception and negotiation of protection among poor homosexual males on the Peruvian coast]. Cad Saude Publica (2006) 1.04
Underutilization of dental care when it is freely available: a prospective study of the New England Children's Amalgam Trial. J Public Health Dent (2008) 1.04
Effects of patient medication requests on physician prescribing behavior: results of a factorial experiment. Med Care (2014) 1.04